|
New Delhi, Jan 12: Bharat Biotech on Tuesday said it has signed an agreement with Precisa Medicamentos for the supply of its COVID-19 vaccine ‘Covaxin’ to Brazil.
Covaxin has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology, the company said in a statement.
Representational Image
“The COVID-19 pandemic has affected humanity at large. As a company determined to protect global public health, it has always been important for us to develop vaccines for a global cause,” Bharat Biotech Chairman and MD Krishna Ella said.
Covaxin is an innovation and a perfect example of novel product development from India, he added.
“Covaxin…
